⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

Official Title: Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil

Study ID: NCT06014580

Interventions

Observational study

Study Description

Brief Summary: An evaluation of the molecular and epidemiological aspects of endometrial cancer in Brazil is necessary to understand the high frequency of advanced disease. A better understanding of the current situation will generate essential data for the future development of national or international cooperative programs that aim to improve outcomes in these patients and generate additional knowledge for much-needed clinical trials in this population.

Detailed Description: This is a retrospective observational cohort study. In this study, we will include patients diagnosed with endometrium cancer from January 2016 to December 2019 in participating sites and collect data on demographics, clinicopathological characteristics, treatment patterns, and outcomes. Data will be collected from medical records in selected centers that comprise different regions of Brazil. The patient data sources will be the medical records of the patients. Patients will continue to receive treatment and clinical evaluations for endometrial cancer according to what is determined by their medical team, according to the usual standards of treatment and clinical practice of each center. To minimize patient selection bias, physicians should invite all consecutive eligible patients. This study also provides for the collection and archiving of tumor tissue material. The samples will be tested to characterize the molecular subtype of endometrial cancer and will be sequentially stored in a biorepository to enable future translational studies, according to national regulations.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Santa Casa de Misericórdia de Feira de Santana, Feira De Santana, Bahia, Brazil

ICC - Instituto do Câncer do Ceará, Fortaleza, Ceará, Brazil

Hospital Evangélico de Cachoeiro de Itapemirim - Centro de Pesquisas Clínicas em Oncologia (CPCO), Cachoeiro De Itapemirim, Espírito Santo, Brazil

Clinica Prognóstica - Centro de Pesquisa Clínica Onconeo, Campo Grande, Mato Grosso Do Sul, Brazil

Instituto do Câncer Brasil - Unidade Três Lagoas, Três Lagoas, Mato Grosso Do Sul, Brazil

UOPECCAN - Hospital do Câncer de Cascavel, Cascavel, Santa Catarina, Brazil

INCA - Instituto Nacional de Câncer, Rio De Janeiro, , Brazil

Contact Details

Name: Andreia Cristina de Melo

Affiliation: Latin American Cooperative Oncology Group

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: